|First-year experiences with the Interagency Guidelines for Drug Donations (WHO/EDM, 2000, 51 p.)|
|3. Dissemination and uptake of the Guidelines|
Drug Policy Issues for Senior Managers, Boston, March 1996
At this international training course, jointly organized by the School of Public Health of Boston University and WHO/DAP, the Guidelines were presented to 38 senior pharmaceutical managers from 28 developing countries. In an official letter to WHO they later proposed that the minimum expiry dating be extended to 18 months. The Guidelines were presented and discussed at each subsequent annual international training course on drug policy issues.
UK-Romania Drugs Advisory Group meeting, London, April
This nongovernmental organization was formed following reports of poor-quality drug donations to Romania. Problems with drug donations were discussed, and the Guidelines were distributed. Organizations in attendance were: Agents for Change, Christ Church Aid for Romania, Clinical Sciences Foundation, ECHO International Health Services, Express Aid International, Health Action International, Jolinda International, Jubilee Outreach Yorkshire, Kings Church Romania Fund, Linx SRL, Medical Support for Romania, Mission Romania (St Albans), Relief Fund for Romania, Romania at Heart, Romania Information Centre, Royal College of General Practitioners and SOS Romania.
Effective Drug Management and Rational Drug Use training course,
Aberdeen, June 1996
The Guidelines were presented and discussed at this training course run by the Robert Gordon University in Aberdeen in June-July 1996. This topic then became part of the curriculum of this annual course for senior pharmacists from developing countries.
8th International Conference of Drug Regulatory Authorities,
Bahrain, November 1996
The Guidelines were presented to about 135 national regulatory authorities. In the discussion it was suggested that the following wording be added: "The donor may be asked to pay the cost of quality control testing and the cost of destroying expired or unusable drugs".
Corporate Partnerships for Development, Washington DC, December
This was a meeting on collaboration with the private sector organized jointly by the World Bank and International Medical Services for Health. One afternoon session was devoted to a forum discussion on drug donations. WHO participated and the Guidelines were presented and discussed. About 50-60 United States private voluntary organizations and pharmaceutical industries took part.
Conference on the WHO Guidelines for Drug Donations - Notre Dame
Center for Ethics and Religious Values in Business, Notre Dame, USA, April
The Guidelines were presented by WHO staff and discussed at this national conference, which was attended by over 100 participants from the United States pharmaceutical industry, private voluntary organizations and other groups, and three representatives from developing countries.
Drug Donation Round Table, New York, September 1998
WHO presented the first outcome of the review of experiences with the Guidelines at a meeting organized by the UN/NGO Health Committee, and supported by Pfizer. It was attended by about 40 representatives from the United States Government, pharmaceutical industry and private voluntary organizations.
Towards Appropriate Drug Donations from the European Union,
Leiden, Netherlands, June 1999
Meeting organized by the Dutch Wemos Foundation.